Expanding targets of vitamin D receptor activation: downregulation of several RAS components in the kidney

Related Experiment Videos

Ilkka H Pörsti1

  • 1Medical School, University of Tampere, Department of Internal Medicine, Tampere University Hospital, Tampere, Finland. ilkka.porsti@uta.fi

Kidney International
|November 15, 2008
PubMed

Insights

Vitamin D receptor (VDR) activation benefits kidney disease by reducing key proteins in the renin-angiotensin system. This leads to lower blood pressure and less kidney damage in rats.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Experimental renal insufficiency is a growing concern.
  • The role of the renin-angiotensin system in kidney disease progression is complex.
  • Vitamin D receptor (VDR) activation has shown potential benefits in managing kidney conditions.

Discussion:

  • VDR activation significantly downregulates the expression of angiotensinogen, angiotensin II type 1 receptor, and renin receptor in the kidneys.
  • These molecular changes correlate with observable improvements in renal health.
  • The study provides mechanistic insights into how VDR activation exerts its protective effects on the kidneys.

Key Insights:

  • VDR activation suppresses key components of the renin-angiotensin system in the kidneys of rats with 5/6 nephrectomy.
  • This suppression is linked to reduced blood pressure and urinary protein excretion.
  • Alleviated renal tissue damage is a significant outcome of VDR activation in this model.

Outlook:

  • VDR agonists may represent a novel therapeutic strategy for chronic kidney disease.
  • Further research is warranted to explore the clinical efficacy and safety of VDR activation in human kidney disease.
  • Understanding the precise molecular pathways involved can lead to targeted therapeutic interventions.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...